PUBLIC COMPANY
saveCSL Behring LLC
updated 5mo ago
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acquired since 2004.
community read0 votes
pipeline
10
marketed
10
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(10)
pipeline depth10 products
10Marketed
Marketed
(coagulation factor VIII (human) + von willebrand factor complex (human))
Hemophilia A (Factor VIII Deficiency)
MarketedC1 esterase inhibitor (human)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
MarketedHaegarda
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
MarketedKcentra
Bleeding And Clotting Disorders
Marketedalbutrepenonacog alfa LA
Hemophilia B (Factor IX Deficiency)
Marketedantihemophilic factor (recombinant), single chain
Hemophilia A (Factor VIII Deficiency)
Marketedcytomegalovirus immune globulin (human)
Cytomegalovirus (HHV-5) Infections
Marketedetranacogene dezaparvovec
Hemophilia B (Factor IX Deficiency)
Marketedfactor XIII (human)
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficie…
Marketedgaradacimab
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Regeneron posts positive phase 2 data for baloncibart in nervous system disorder, eyes pivotal trialRegeneron has posted positive phase 2 data on baloncibart in postural orthostatic tachycardia syndrome, teeing the biotech up to start a potentially pivotal trial in the first half of 2027.fiercebiotech · 4d ago
- BioSpace 2027 Best Places to Work shines light on most admired employersThe list honors 50 life sciences employers of choice. Employees at SERB Pharmaceuticals and CSL Behring share why their companies stand out.biospace · 7d ago
- STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and moreIn today's Pharmalittle newsletter, drug pricing deals, a new cancer therapy approval, and more of the latest pharma headlines.stat · 2mo ago
- Chiesi to buy KalVista in $1.9B deal for rare disease drugThe acquisition is the fifth of a biotech company so far this week and, according to some Wall Street analysts, proves pharma’s interest in new and emerging oral therapies for hereditary angioedema.biopharma_dive · 6mo ago
- Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campusThe 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.biopharma_dive · 6mo ago
comments(0)
5-min edit window · permanent after that